This pattern recognition tool runs Ladder Bottom recognition and companion studies for Outset Medical. The focus on pattern recognition signals tied to momentum and continuation helps organize trend, volatility, and risk context for Outset Medical.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was fourteen with a total number of output elements of forty-seven. The function did not return any valid pattern recognition events for the selected time horizon. The Ladder Bottom is a reversal pattern describing Outset Medical bullish trend.
Outset Medical Technical Analysis Modules
Most technical analysis of Outset Medical help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Outset from various momentum indicators to cycle indicators. When you analyze Outset charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California. Outset Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 444 people. Market structure and macro sensitivity help explain how Outset Medical behaves across regimes. Some cyclical sensitivity may emerge during periods of macroeconomic volatility. Outset Medical has a market cap of 57.86 M, ROE of -106.2%.
Methodology
Unless otherwise specified, financial data for Outset Medical is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Outset (USA Stocks:OM) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: This report references public filings and market reference sources and institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Certain datasets may update with delay depending on source availability. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Outset Medical is covered by 4 analysts. 2 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Morgan Stanley, Goldman Sachs, Citigroup, Raymond James, Deutsche Bank, among others. Updates may occur throughout the day.
Tracking Outset Medical inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.
Generate Optimal Portfolios
Align your risk and return expectations
By capturing risk tolerance and investment horizon, Macroaxis optimization evaluates acceptable risk for target return profiles. The process summarizes how much risk can be taken for a given return goal.
Outset Medical has a market cap of 57.86 M, operating margin of -61.06%, ROE of -106.2%. Review Your Equity Center for broader portfolio context. This reflects a position in Outset Medical within the allocation view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
Before investing in Outset Stock, review our How to Buy Outset Medical guide for key considerations.Analysis related to Outset Medical should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Earnings Share
-5.37
Revenue Per Share
7.855
Quarterly Revenue Growth
-0.02
Return On Assets
-0.15
Return On Equity
-1.06
Understanding Outset Medical includes distinguishing between market value and book value, where book value reflects Outset's accounting equity. Outset Medical's market capitalization is 57.86 M. A P/B ratio of 0.46 suggests Outset Medical trades near or below book value. Intrinsic value reflects what Outset Medical's fundamentals imply about worth, which may differ from both the trading price and the book figure. Analytical frameworks help reconcile those views.
It is useful to distinguish Outset Medical's value from its trading price, which are computed with different methods. For Outset Medical, key inputs include a P/B ratio of 0.46, a profit margin of -68.34%, ROE of -106.2%, and revenue of 119.48 M. The quoted price is simply the exchange level where supply meets demand.